Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Hospitals-II

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in hospitals have...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PECOS Confusion: Who Has to Enroll? Don't Ask.

Texas medicine·2016

Same author

The new TMB: board improves licensing, enforcement processes.

Texas medicine·2014

Same author

Doctor's orders followed: TMA scores victories despite tough legislative session.

Texas medicine·2014

Same author

False hope?

Texas medicine·2012

Same author

Better quality.

Texas medicine·2012

Same author

Keep insurers honest.

Texas medicine·2012

Search research articles

Related Experiment Video

Updated: May 19, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

Doctors targeted.

|August 3, 2012

Summary

This summary is machine-generated.

The Federal Trade Commission (FTC) is now involved in healthcare scope-of-practice regulations, impacting state dental boards. This intervention raises concerns among medical professionals and licensing bodies about potential prioritization of competition over patient safety.

More Related Videos

Targeted Knockdown of Genes in the Choroid Plexus

Targeted Knockdown of Genes in the Choroid Plexus

Published on: June 16, 2023

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: May 19, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

Targeted Knockdown of Genes in the Choroid Plexus

Targeted Knockdown of Genes in the Choroid Plexus

Published on: June 16, 2023

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Area of Science:

Healthcare Regulation
Public Policy
Medical Practice

Background:

The Federal Trade Commission (FTC) has begun intervening in state-level scope-of-practice regulations.
South Carolina dental regulators have faced scrutiny from the FTC.
This involvement has created apprehension within organized medicine and state licensing boards.

Purpose of the Study:

To analyze the FTC's increasing role in scope-of-practice determinations.
To examine the implications of FTC intervention on state medical and dental boards.
To assess the potential conflict between competition and patient safety in regulatory oversight.

Main Methods:

Review of FTC actions and statements regarding scope-of-practice.
Analysis of responses from medical and dental professional organizations.
Examination of state licensing board concerns.

Main Results:

FTC engagement in scope-of-practice issues is a developing trend.
State regulators, particularly in dentistry, are directly affected.
Concerns exist that the FTC may prioritize market competition over patient safety considerations.

Conclusions:

The FTC's involvement in scope-of-practice presents a new challenge for state regulatory bodies.
There is a perceived risk that the FTC's focus on competition could undermine patient safety measures.
Organized medicine and licensing boards are monitoring these developments closely.